This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Children's Medical Center Corporation, Harvard College. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018
Title: Tadanori Mammoto: Innovator in Ex Vivo Tissue Culture Systems
Introduction
Tadanori Mammoto is an innovative inventor based in the United States. He has made significant contributions to the field of tissue engineering, particularly through his work on methods and devices for ex vivo tissue culture systems. His research focuses on creating functional organ structures that can be developed within an implantation device.
Latest Patents
Tadanori Mammoto holds a patent titled "Methods And Uses For Ex Vivo Tissue Culture Systems." This technology is designed to induce functional organ structures to form within an implantation device by implanting it in vivo within the body of a living animal. The process allows cells and tissues to impregnate the implantation device, establishing normal microenvironmental architecture and tissue-tissue interfaces. The contained cells and tissues can then be surgically removed intact and either transplanted into another animal or maintained ex vivo by perfusing them through fluid channels with the necessary medium and gases for cell survival.
Career Highlights
Throughout his career, Tadanori Mammoto has worked with prestigious institutions such as Harvard College and Children's Medical Center Corporation. His research has contributed to advancements in the understanding of tissue engineering and regenerative medicine.
Collaborations
Tadanori Mammoto has collaborated with notable individuals in his field, including Donald Elliot Ingber and Yusuke Torisawa. These collaborations have furthered the development of innovative solutions in tissue culture systems.
Conclusion
Tadanori Mammoto is a prominent figure in the field of tissue engineering, with a focus on ex vivo tissue culture systems. His work has the potential to revolutionize organ transplantation and regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile